As of Nov 27
| +0.31 / +2.65%|
The 6 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 16.50, with a high estimate of 24.00 and a low estimate of 15.00. The median estimate represents a +37.27% increase from the last price of 12.02.
The current consensus among 6 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.